Streamline Health Solutions, Inc.

NasdaqCM:STRM Stock Report

Market Cap: US$16.5m

Streamline Health Solutions Past Earnings Performance

Past criteria checks 0/6

Streamline Health Solutions's earnings have been declining at an average annual rate of -37.5%, while the Healthcare Services industry saw earnings growing at 23.3% annually. Revenues have been growing at an average rate of 15.4% per year.

Key information

-37.5%

Earnings growth rate

-23.4%

EPS growth rate

Healthcare Services Industry Growth1.7%
Revenue growth rate15.4%
Return on equity-67.5%
Net Margin-50.5%
Last Earnings Update31 Oct 2024

Recent past performance updates

Recent updates

Streamline Health Solutions, Inc. (NASDAQ:STRM) Stock Catapults 39% Though Its Price And Business Still Lag The Industry

Nov 19
Streamline Health Solutions, Inc. (NASDAQ:STRM) Stock Catapults 39% Though Its Price And Business Still Lag The Industry

Is Streamline Health Solutions (NASDAQ:STRM) Using Too Much Debt?

Nov 12
Is Streamline Health Solutions (NASDAQ:STRM) Using Too Much Debt?

Why Investors Shouldn't Be Surprised By Streamline Health Solutions, Inc.'s (NASDAQ:STRM) 42% Share Price Plunge

Sep 13
Why Investors Shouldn't Be Surprised By Streamline Health Solutions, Inc.'s (NASDAQ:STRM) 42% Share Price Plunge

Streamline Health Solutions (NASDAQ:STRM) Is Making Moderate Use Of Debt

Aug 14
Streamline Health Solutions (NASDAQ:STRM) Is Making Moderate Use Of Debt

Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Share Price Boosted 46% But Its Business Prospects Need A Lift Too

Jun 21
Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Share Price Boosted 46% But Its Business Prospects Need A Lift Too

Streamline Health Solutions, Inc. (NASDAQ:STRM) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

May 07
Streamline Health Solutions, Inc. (NASDAQ:STRM) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Revenues Working Against Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Share Price Following 26% Dive

Jan 26
Revenues Working Against Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Share Price Following 26% Dive

Revenue Downgrade: Here's What Analysts Forecast For Streamline Health Solutions, Inc. (NASDAQ:STRM)

Dec 16
Revenue Downgrade: Here's What Analysts Forecast For Streamline Health Solutions, Inc. (NASDAQ:STRM)

Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?

Dec 07
Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?

Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Intrinsic Value Is Potentially 76% Above Its Share Price

Oct 04
Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Intrinsic Value Is Potentially 76% Above Its Share Price

Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?

Sep 07
Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?

There's Reason For Concern Over Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Price

Jul 26
There's Reason For Concern Over Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Price

Health Check: How Prudently Does Streamline Health Solutions (NASDAQ:STRM) Use Debt?

Jan 31
Health Check: How Prudently Does Streamline Health Solutions (NASDAQ:STRM) Use Debt?

Streamline Health GAAP EPS of -$0.07 in-line, revenue of $5.99M beats by $0.79M

Sep 07

Streamline Health rallies after signing new contract with care delivery client based in Southwest

Jul 20

We Think Streamline Health Solutions (NASDAQ:STRM) Has A Fair Chunk Of Debt

Jun 08
We Think Streamline Health Solutions (NASDAQ:STRM) Has A Fair Chunk Of Debt

Streamline Health Solutions (NASDAQ:STRM) Has Debt But No Earnings; Should You Worry?

Feb 11
Streamline Health Solutions (NASDAQ:STRM) Has Debt But No Earnings; Should You Worry?

Need To Know: This Analyst Just Made A Substantial Cut To Their Streamline Health Solutions, Inc. (NASDAQ:STRM) Estimates

Dec 11
Need To Know: This Analyst Just Made A Substantial Cut To Their Streamline Health Solutions, Inc. (NASDAQ:STRM) Estimates

Streamline Health Solutions, Inc. Is A Massive Medical SaaS Opportunity

Dec 03

Is Streamline Health Solutions (NASDAQ:STRM) A Risky Investment?

Jul 27
Is Streamline Health Solutions (NASDAQ:STRM) A Risky Investment?

Streamline Health Solutions, Inc. 2021 Q1 - Results - Earnings Call Presentation

Jun 09

Is Streamline Health Solutions (NASDAQ:STRM) Using Debt Sensibly?

Dec 11
Is Streamline Health Solutions (NASDAQ:STRM) Using Debt Sensibly?

Revenue & Expenses Breakdown

How Streamline Health Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:STRM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 2419-9125
31 Jul 2420-19135
30 Apr 2422-19145
31 Jan 2423-19156
31 Oct 2324-20166
31 Jul 2324-11166
30 Apr 2324-11166
31 Jan 2325-11166
31 Oct 2224-9166
31 Jul 2223-10156
30 Apr 2220-7145
31 Jan 2217-7125
31 Oct 2114-9104
31 Jul 2111-594
30 Apr 2111-693
31 Jan 2111-593
31 Oct 2011-693
31 Jul 2012-193
30 Apr 2012-293
31 Jan 2012-1103
31 Oct 1915-2103
31 Jul 1916-6103
30 Apr 1919-6104
31 Jan 1922-6114
31 Oct 1823-3115
31 Jul 1824-2115
30 Apr 1825-2115
31 Jan 1824-3115
31 Oct 1725-4126
31 Jul 1725-6127
30 Apr 1726-6137
31 Jan 1727-6137
31 Oct 1627-7138
31 Jul 1628-6128
30 Apr 1629-5139
31 Jan 1628-6139
31 Oct 1529-91510
31 Jul 1528-111610
30 Apr 1527-121710
31 Jan 1528-131610
31 Oct 1428-101710
31 Jul 1427-14169
30 Apr 1429-13158
31 Jan 1428-13157

Quality Earnings: STRM is currently unprofitable.

Growing Profit Margin: STRM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: STRM is unprofitable, and losses have increased over the past 5 years at a rate of 37.5% per year.

Accelerating Growth: Unable to compare STRM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: STRM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17.5%).


Return on Equity

High ROE: STRM has a negative Return on Equity (-67.47%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 22:29
End of Day Share Price 2025/01/08 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Streamline Health Solutions, Inc. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard CloseAvondale Partners
null nullCG Capital
Kyle BauserColliers Securities